Genta, Inc (fka GNTAQ)

[garza]

February 2, 2009: Genta Incorporated (OTCBB: GNTA | Quote | Chart | News | PowerRating) announced today that the Company's Chairman and Chief Executive Officer, Dr. Raymond P. Warrell, Jr., will provide a company overview and update of corporate activities at the 11th annual BIO CEO & Investor Conference. The presentation is scheduled for Monday, February 9th at 10:00 am ET at the Waldorf-Astoria Hotel, New York, NY. In addition, Dr. Warrell will be a panelist in the BIO CEO therapeutic workshop, "Oncology: The Forecast for the Melanoma Market-Partly Sunny or Mostly Cloudy", at 12:30 pm (ET) on Tuesday, February 10th. Expert panelists include Dr. Gary Schwartz, Chief, Melanoma/Sarcoma Service, Memorial Sloan Kettering Cancer Center, and Dr. Anna Pavlick, Assistant Professor of Medicine and Dermatology, and Director of the NYU Cancer Institute Melanoma Research Program, NYU Medical Center, who is an investigator on the Company's Phase 3 AGENDA trial of Genasense in patients with advanced melanoma. The presentation will be webcast and accessible at the Investor Relations section of the Company's website at: http://www.genta.com/investorrelation/events.html. The presentation will be archived for 30 days. The panel will not be webcast.

http://www.tradingmarkets.com/.site/news/Stock%20News/2158112/